Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-026991

Director sold 580 shares at an average $348.28 ($202,004)

  • Director acquired 1,168 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bhatia Sangeeta N. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-01 Grant or award : show line 1 in the form 10b5-1 +1,168 5,208 D
2023-05-02 Sale : show line 2 in the form 10b5-1 −62 $345.93 $21,448 5,146 D
2023-05-02 Sale : show line 3 in the form 10b5-1 −172 $346.69 $59,631 4,974 D
2023-05-02 Sale : show line 4 in the form 10b5-1 −120 $348.16 $41,779 4,854 D
2023-05-02 Sale : show line 5 in the form 10b5-1 −163 $349.82 $57,021 4,691 D
2023-05-02 Sale : show line 6 in the form 10b5-1 −63 $351.20 $22,126 4,628 D
Open-market sales · 580 sh · avg $348.28 · $202,004
Loading xslF345X04/doc4.xml…